Provexis (LON:PXS) Issues Quarterly Earnings Results

Provexis (LON:PXS – Get Free Report) issued its quarterly earnings data on Thursday. The company reported GBX (0.02) earnings per share for the quarter, Digital Look Earnings reports. Provexis had a negative return on equity of 49.45% and a negative net margin of 69.30%.

Provexis Stock Up 2.8%

Shares of LON PXS opened at GBX 0.95 on Thursday. Provexis has a 52-week low of GBX 0.55 and a 52-week high of GBX 1.55. The stock has a market capitalization of £22.31 million, a PE ratio of -47.55 and a beta of 0.66. The firm has a fifty day moving average of GBX 1.05 and a 200-day moving average of GBX 1.07.

Get Provexis alerts:

Provexis Company Profile

(Get Free Report)

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function.

Recommended Stories

• Five stocks we like better than Provexis
• Cleared for Takeoff: AAR Corp. Expands Its Aerospace Aftermarket Reach
• L3Harris’ $6 Billion THAAD Win Comes at a Crucial Moment for the Stock
• Boeing’s Fighter Victory Opens the Door to Decades of Defense Revenue
• Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?

Receive News & Ratings for Provexis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Provexis and related companies with MarketBeat.com's FREE daily email newsletter.